What Researchers Did
Researchers retrospectively reviewed patient records to compare how different hyperbaric oxygen (HBOT) treatments affected the development of delayed brain and nerve problems after carbon monoxide poisoning.
What They Found
Of 312 patients, the incidence of delayed neuropsychiatric sequelae was 36% for 2.0ATA once, 37% for 2.0ATA thrice, 20% for 2.8ATA once, and 19% for 2.8ATA thrice. Patients treated with higher-pressure HBOT (2.8ATA once or thrice) had a significantly lower rate of these delayed issues (19.3%) compared to those treated with lower-pressure HBOT (2.0ATA once or thrice), which had a 36.2% rate. The higher-pressure protocol was independently associated with a 55% reduction in the odds of developing delayed neuropsychiatric sequelae.
What This Means for Canadian Patients
For Canadians who have experienced carbon monoxide poisoning, this study suggests that higher-pressure hyperbaric oxygen therapy (2.8ATA) may be more effective in preventing long-term brain and nerve issues. This information could help doctors in Canada choose the most beneficial HBOT protocol to improve patient recovery and reduce the risk of delayed complications.
Canadian Relevance
This study covers carbon monoxide poisoning, which is a Health Canada-recognized indication for hyperbaric oxygen therapy.
Study Limitations
A limitation of this study is its retrospective design, which means it relied on existing patient records and may be subject to biases inherent in such data collection.